image
Apogee Therapeutics, Inc. APGE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 39.31
0.795 %
$ 2.34 B
Market Cap
-10.89
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
--13.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Apogee Therapeutics, Inc.
image
APGE has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart APGE

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart APGE

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart APGE

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)($500.0m)($500.0m)20232023202420242025202520262026202720272028202820292029